These data, as well as our genomic analyses of xenografts (33.3%, SMARCB1 or PBRM1-mutated PDXs), reinforce that epigenetic dysregulation may play an important role in the development of chordoma, especially through driver events affecting SMARCB1 and PBRM1 genes. The gene discussed is SMARCB1; the disease is chordoma.